Expanding the Business Through Strategic Partnerships and OEM Supply
First written in FY2018. 7 of 15 entries say "Advanced", first in FY2019. Latest entry: 2026-09-24.
61 other companies' latest entry also says "Advanced".
- 2026-09-24Advancednews.nicovideo.jp
「総医研ホールディングス has entered into an agreement with a group company of Sichuan Kelun Pharmaceutical Group, a major Chinese pharmaceutical company, establishing a framework for joint research into new functional materials.」
The company reportedly entered into a joint research agreement with a group company of a major Chinese pharmaceutical company, advancing the strategic partnership to the stage of a concrete agreement. - FY2025RaisedAnnual report
「Going forward, the Company plans to enter into strategic M&A transactions, business alliances and other arrangements with companies expected to generate synergies in each business, including business expansion through active acquisitions centered on the healthcare business, particularly medical DX, to expand the scope of its existing businesses and build a comprehensive healthcare platform, and business alliances to enhance content on the comprehensive healthcare platform, thereby expanding its business scope and optimizing the allocation of management resources.」
The scope has expanded from the previous strategic alliance policy to include acquisitions through active M&A centered on medical DX and business alliances aimed at enhancing platform content. - FY2025-H1AdvancedAnnual report
「For sales of products for the Chinese market, orders for direct transactions with 高浪控股股份有限公司, the capital and business alliance partner scheduled for the previous period, were placed during the current interim consolidated accounting period.」
Orders for direct transactions with the capital and business alliance partner, which had been scheduled for the previous period, were placed during the current interim consolidated accounting period. The situation has progressed from the previous period's delay in starting direct transactions to the concrete transaction stage. - FY2024Delay in starting direct transactions with the alliance partnerAnnual report
「A delay occurred in the timing of the start of direct transactions with 高浪控股股份有限公司, the Company's capital and business alliance partner, and」
The capital and business alliance with the Chinese distribution company continues, but the start of direct transactions with the alliance partner has been delayed, resulting in changes in the execution of the sales expansion strategy. - FY2023RestatedAnnual report
「The Group plans to enter into strategic business alliances and other arrangements with companies that are expected to generate business synergies, expanding its business scope and optimizing the allocation of management resources.」
The Company continues its policy of expanding its business through strategic alliances, citing the capital and business alliance with the Chinese distribution company as a track record. - FY2021-Q3RestatedAnnual report
「Wholesale revenue was ¥3,562 million, up 8.6% year on year. Sales of products for the Chinese market, centered on “モイストクリームマスクPro.”, showed a decline in the third quarter of the current consolidated accounting period, partly due to a reaction to strong sales at Alibaba Group’s major shopping event “天猫ダブルイレブン” in November 2020. However, sales increased over the current consolidated cumulative period as a whole, due in part to higher sales at the event and the effect of the capital and business alliance concluded in February 2019 with the Chinese distribution company 杭州高浪控股有限公司.」
The capital and business alliance entered into with the Chinese distribution company in February 2019 continues to contribute to higher cumulative sales of products for the Chinese market. No new alliance agreement is mentioned. - FY2021-Q2RestatedAnnual report
「Wholesale revenue was ¥2,843 million, up 32.9% year on year. Sales of products for the Chinese market, centered on “モイストクリームマスクPro.”, continued to trend upward, partly due to the effect of the capital and business alliance concluded in February 2019 with the Chinese distribution company 杭州高浪控股有限公司.」
The capital and business alliance entered into with the Chinese distribution company in February 2019 continues to contribute to increased sales of products for the Chinese market. No new alliance agreement is mentioned. - FY2021-Q1RestatedAnnual report
「Sales of products for the Chinese market followed an upward trend year on year, partly as a result of the capital and business alliance entered into in February 2019 with Hangzhou Golong Holding Co., Ltd., a Chinese distribution company.」
The capital and business alliance with the Chinese distribution company continues to contribute to increased sales of products for the Chinese market. No new alliance agreement is mentioned. - FY2020RestatedAnnual report
「In particular, the capital and business alliance entered into in February 2019 with Hangzhou Golong Holding Co., Ltd., a Chinese distribution company, has substantially increased sales of products for the Chinese market in the cosmetics business through the results of cooperation with the company, making a significant contribution to the expansion of the Group's performance.」
The full-year disclosure reconfirms that the capital and business alliance with the Chinese distribution company contributed to increased sales of products for the Chinese market and expanded business performance. - FY2020-Q2AdvancedAnnual report
「Wholesale revenue was ¥2,139 million, up 67.6% year on year. Sales of products for China’s cross-border e-commerce market, centered on “モイストクリームマスクPro.”, continued to expand, partly due to the capital and business alliance concluded in February 2019 with the Chinese distribution company 杭州高浪控股有限公司.」
The effects of the capital and business alliance with the Chinese distribution company have appeared in expanded sales of products for cross-border e-commerce in China, quantifying the business expansion resulting from the alliance. - FY2019AdvancedAnnual report
「Entered into a capital and business alliance agreement with Chinese distribution company Hangzhou Golong Holding Co.,Ltd. for the purpose of establishing an alliance concerning the sale of cosmetics and health supplements and other products in the Chinese market.」
In February 2019, the Company entered into a capital and business alliance agreement with Chinese distribution company Hangzhou Golong Holding Co.,Ltd. The policy of expanding sales in the Chinese market through a strategic alliance has progressed to a specific agreement. - FY2018First statedAnnual report
「The Group plans to enter into strategic business alliances and other arrangements with companies that are expected to generate business synergies, expanding its business scope and optimizing the allocation of management resources.」
Based on its track record, including the joint venture with Hakuhodo and OEM supply to companies with strong sales capabilities, the Company has stated as an independent strategy its policy of expanding its business through strategic alliances and optimizing the allocation of management resources.